NDC 0641-6263 – Sodium Acetate
Sodium Acetate Anhydrous 164 mg/mL · Injection · Intravenous
Product NDC0641-6263
Product details
- Brand name
- Sodium Acetate
- Generic name
- Sodium Acetate
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Dosage form
- Injection
- Route
- Intravenous
- Marketing category
- ANDA · ANDA216920
- Marketed since
- May 20, 2024
- Listing expires
- December 31, 2026
- Pharmacologic class
- Osmotic Laxative
Active ingredients
- Sodium Acetate Anhydrous 164 mg/mL
Uses, dosage, side effects and warnings for Sodium Acetate →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0641-6263-10 | 10 VIAL in 1 CARTON (0641-6263-10) / 100 mL in 1 VIAL (0641-6263-01) | May 20, 2024 |
Other Sodium Acetate products
- 0641-6261 Sodium Acetate Anhydrous 164 mg/mL · Injection · Hikma Pharmaceuticals USA Inc.
- 0641-6262 Sodium Acetate Anhydrous 164 mg/mL · Injection · Hikma Pharmaceuticals USA Inc.
- 80830-2435 Sodium Acetate Anhydrous 164 mg/mL · Injection, Solution, Concentrate · Amneal Pharmaceuticals Private Limited
- 80830-2436 Sodium Acetate Anhydrous 164 mg/mL · Injection, Solution, Concentrate · Amneal Pharmaceuticals Private Limited
- 80830-2437 Sodium Acetate Anhydrous 164 mg/mL · Injection, Solution, Concentrate · Amneal Pharmaceuticals Private Limited
- 63323-032 Sodium Acetate 4 meq/100mL · Injection, Solution, Concentrate · Fresenius Kabi USA, LLC
- 0409-3299 Sodium Acetate Anhydrous 164 mg/mL · Injection, Solution, Concentrate · Hospira, Inc.
- 0409-7299 Sodium Acetate Anhydrous 3.28 g/20mL · Injection, Solution, Concentrate · Hospira, Inc.
- 71357-002 Sodium Acetate 164 mg/mL · Injection, Solution, Concentrate · MILLA PHARMACEUTICALS INC.
- 71357-007 Sodium Acetate 164 mg/mL · Injection, Solution, Concentrate · MILLA PHARMACEUTICALS INC.
- 71357-008 Sodium Acetate 200 meq/100mL · Injection, Solution, Concentrate · MILLA PHARMACEUTICALS INC.
- 71357-009 Sodium Acetate 400 meq/100mL · Injection, Solution, Concentrate · MILLA PHARMACEUTICALS INC.